<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated impact of ivabradine on exercise capacity and quality of life in patients with stable <z:mp ids='MP_0006112'>angina</z:mp> and comorbid <z:hpo ids='HP_0006510'>chronic obstructive pulmonary disease</z:hpo> during treatment with -blockers </plain></SENT>
<SENT sid="1" pm="."><plain>Ivabradine with -blockers <z:mp ids='MP_0005333'>reduced heart rate</z:mp>, increased exercise capacity and improved <z:mp ids='MP_0006112'>angina</z:mp> more effective than -blockers only </plain></SENT>
<SENT sid="2" pm="."><plain>Quality of life associated with <z:mp ids='MP_0006112'>angina</z:mp> increased in patients with stage I and II <z:hpo ids='HP_0006510'>chronic obstructive pulmonary disease</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Addition of ivabradine to -blockers for 2 month did not produce adverse respiratory effects </plain></SENT>
</text></document>